Trump's drug price hopes focus on abroad
The article discusses the Trump administration's efforts to reduce U.S. prescription drug prices by negotiating better deals with foreign governments. It emphasizes that foreign countries have long used policies to suppress drug costs, shifting more financial burden onto American patients. The strategy involves pressuring countries like the UK and Germany to pay more for medicines, aiming to increase revenue for U.S. pharmaceutical innovation and ensure continued research and development. The goal is to foster fair international contributions that support domestic industry and lower patient costs.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)